COLAO, ANNAMARIA
 Distribuzione geografica
Continente #
NA - Nord America 17.028
EU - Europa 8.892
AS - Asia 6.445
AF - Africa 363
SA - Sud America 86
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 24
Totale 32.862
Nazione #
US - Stati Uniti d'America 16.668
SG - Singapore 3.132
IT - Italia 2.758
CN - Cina 2.612
SE - Svezia 1.079
NL - Olanda 1.051
DE - Germania 938
IE - Irlanda 917
FI - Finlandia 907
UA - Ucraina 523
CA - Canada 331
VN - Vietnam 321
CI - Costa d'Avorio 314
GB - Regno Unito 281
FR - Francia 144
IN - India 114
TR - Turchia 82
BE - Belgio 49
CZ - Repubblica Ceca 42
ES - Italia 42
BR - Brasile 36
IR - Iran 32
RU - Federazione Russa 30
MX - Messico 25
EG - Egitto 24
EU - Europa 24
HK - Hong Kong 22
AU - Australia 21
RO - Romania 21
PL - Polonia 18
JP - Giappone 17
ID - Indonesia 16
KR - Corea 16
CL - Cile 15
IQ - Iraq 13
AR - Argentina 12
AT - Austria 12
CH - Svizzera 12
CO - Colombia 12
TW - Taiwan 12
DK - Danimarca 9
HU - Ungheria 9
AE - Emirati Arabi Uniti 7
IL - Israele 7
NG - Nigeria 7
PE - Perù 7
PH - Filippine 7
PT - Portogallo 7
ZA - Sudafrica 7
TH - Thailandia 6
BG - Bulgaria 5
GR - Grecia 5
HR - Croazia 5
NO - Norvegia 5
MY - Malesia 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
DZ - Algeria 3
EC - Ecuador 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
BF - Burkina Faso 2
ET - Etiopia 2
GE - Georgia 2
HT - Haiti 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LI - Liechtenstein 2
LT - Lituania 2
LV - Lettonia 2
MC - Monaco 2
NP - Nepal 2
UG - Uganda 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
KH - Cambogia 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 32.862
Città #
Chandler 3.171
Singapore 2.487
Millbury 1.324
Amsterdam 998
Princeton 911
Jacksonville 844
Nanjing 826
Santa Clara 746
Ashburn 728
Naples 632
Wilmington 495
Napoli 463
Beijing 448
Boston 349
Des Moines 314
Dong Ket 313
Ottawa 273
Nanchang 222
Woodbridge 210
Hebei 171
Lawrence 170
Norwalk 147
Shenyang 139
Munich 134
Jiaxing 119
Ann Arbor 115
Seattle 111
Boardman 103
Houston 101
Rome 94
Tianjin 85
Changsha 75
Helsinki 75
Kronberg 75
Redwood City 74
Milan 73
Falls Church 72
Kunming 71
Dublin 67
Pune 56
Washington 52
Dearborn 46
Indiana 46
Buffalo 43
Fairfield 42
Brno 37
Dallas 36
San Mateo 34
Los Angeles 33
New York 32
Redmond 27
Shanghai 25
Lappeenranta 24
Paris 24
Guangzhou 23
Hangzhou 23
Jinan 22
Lanzhou 22
San Francisco 20
Ardabil 19
Changchun 19
Montréal 19
Toronto 19
Frankfurt am Main 18
Istanbul 18
Portici 18
Augusta 16
Hong Kong 16
Marigliano 16
Prineville 16
Tappahannock 16
Courcelles 15
London 15
Mcallen 15
Ningbo 15
Zhengzhou 15
Torino 14
Bologna 13
Duncan 13
Orange 13
Salerno 13
Altamura 12
Mountain View 10
Philadelphia 10
Sandston 10
Springfield 10
Yellow Springs 10
Afragola 9
Cagliari 9
Caserta 9
Council Bluffs 9
Ledegem 9
Stockholm 9
Taizhou 9
Atlanta 8
Bari 8
Dongguan 8
Elmas 8
Florence 8
Mumbai 8
Totale 19.016
Nome #
Systemic complications of acromegaly: epidemiology, pathogenesis, and management 399
Adenomi Ipofisari 119
Sensori in fibra ottica integrati in aghi impiegati per l'ablazione percutanea, la necrotizzazione e in terapie varie 103
A Community-Based, Technology-Supported Health Service for Detecting and Preventing Frailty among Older Adults: A Participatory Design Development Process 101
Mediterranean diet as medical prescription in menopausal women with obesity: a practical guide for nutritionists 100
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 90
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 84
Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists 82
Coffee consumption, health benefits and side effects: a narrative review and update for dietitians and nutritionists 80
Flavor perception test: evaluation in patients with Kallmann syndrome 77
Cabergoline plus lanreotide for ectopic Cushing's syndrome. 73
Growth hormone deficiency is associated with worse cardiac function, physical performance, and outcome in chronic heart failure: Insights from the T.O.S.CA. GHD study 73
Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis 73
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 72
Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis 72
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 72
Antipituitary antibodies in idiopathic hyperprolactinemic patients 71
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 67
Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency 67
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 65
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 65
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 64
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. 64
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. 64
Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire 63
MEN1 family with a novel frameshift mutation. 63
GH INSUFFICIENCY IN OBESE PATIENTS. 63
Correlation between Seminal Carnitine and Functional Spermatozoal Characteristics in Men with Semen Dysfunction of Various Origins 63
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 62
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours 62
Adverse events associated with somatostatin analogs in acromegaly. 61
Hepatic arterial embolization in patients with neuroendocrine tumors. 60
Neuropsychiatric disorders in Cushing's syndrome. 60
Thyroid function and morphology after a successful kidney transplantation. 60
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 60
ETIOPATOGENESI E CLINICA DELLA SINDROME DELL’OVAIO POLICISTICO 60
Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients 60
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients 59
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 59
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 59
The evolving field of kinase inhibitors in thyroid cancer. 58
GLP-1: benefits beyond pancreas. 58
CORRELATION BETWEEN SEMINAL CARNITINE AND FUNCTIONAL CHARACTERISTICS IN MEN WITH SEMEN DYSFUNCTION OF VARIOUS ORIGINS. 58
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 58
Long period fiber grating nano-optrode for cancer biomarker detection 58
The Treatment of Cushing's Disease. 57
First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 57
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 57
Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome. 57
Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats 57
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 56
High-resolution melting analysis (HRM) for mutational screening of Dnajc17 gene in patients affected by thyroid dysgenesis 56
IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro 55
Cardiopulmonary impairment in young women with polycystic ovary syndrome 55
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study. 54
Self-Assessment of Adherence to Medication: A Case Study in Campania Region Community-Dwelling Population 54
Selenium supplementation modulates apoptotic processes in thyroid follicular cells 54
Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association 54
A 12-month phase 3 study of pasireotide in cushing's disease 53
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 53
The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study 53
Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study. 53
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 53
Accordi di programma "Piattaforme tecnologiche avanzate per la definizione di nuovi biomarkers e bersagli molecolari in vettori nanotecnologici per la diagnosi e la terapia di neoplasie umane" 53
Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D? 53
Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I 52
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 52
The environment and male reproduction: The effect of cadmium exposure on reproductive functions and its implication in fertility 52
The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features. 52
Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women. 52
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR 52
A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO) 52
ACROSTUDY: the Italian experience. 51
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 51
Effects of neridronate treatment in elderly women with osteoporosis 51
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 51
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 51
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. 51
A novel mutation in the N-terminal region of the CYP17A1 gene in a patient with 17 alpha-hydroxylase/17,20-lyase deficiency. 51
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 51
Sunshine vitamin and thyroid 51
The lullaby of the sun: the role of vitamin D in sleep disturbance. 51
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity and Resilience 51
Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study. 50
Flavor identification inversely correlates with Body Mass Index (BMI) 50
Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy. 50
Advances in the treatment of prolactinomas 50
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 50
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 50
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 50
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 50
High Sensitive Long Period Fiber Grating Biosensor for Cancer Biomarker Detection 50
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 49
Comment on Azmahani et al. "Steroidogenic enzymes, their related transcription factors and nuclear receptors in human sebaceous glands under normal and pathological conditions" 49
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 49
Pituitary function and morphology in Fabry disease. 49
Impact of a Very Low-Calorie Ketogenic Diet (VLCKD) on Changes in Handgrip Strength in Women with Obesity 48
CONVENTIONAL AND NUCLEAR MEDICINE IMAGING IN ECTOPIC CUSHING'S SYNDROME: A SYSTEMATIC REVIEW. 48
L'ESPOSIZIONE AMBIENTALE è UN FATTORE DI RISCHIO MASCHILE? 48
Endocrine dysfunction in patients with Fabry disease 48
Totale 6.318
Categoria #
all - tutte 175.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.560 0 0 0 0 184 68 44 40 39 223 396 566
2020/20212.584 50 111 298 143 173 532 177 73 268 110 263 386
2021/20226.503 117 40 68 81 125 695 91 206 1.027 326 1.167 2.560
2022/20237.847 1.188 647 207 645 882 787 138 663 1.071 1.074 418 127
2023/20245.204 243 811 698 388 240 409 191 635 58 99 900 532
2024/20254.634 1.568 1.824 251 342 649 0 0 0 0 0 0 0
Totale 34.332